arrow
G

Giovanni Cazzaniga

university of milano bicocca
H指数:70
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation

供者来源的经 Sleeping Beauty 转座子工程改造的 CARCIK-CD19 细胞在急性淋巴细胞白血病异基因移植后复发。

2025-04-030
OA
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome: ACUTE LYMPHOBLASTIC LEUKEMIA
LEUKEMIA
IF13.4
2024-12-190
OAAI
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia

双等位基因PI4KA突变破坏b细胞代谢并导致b细胞淋巴细胞减少和低丙种球蛋白血症

2024-09-231
PRE
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening

组蛋白去乙酰化酶抑制剂givinostat (ITF2357) 在通过高通量药物筛选鉴定的CRLF2-rearranged小儿b细胞前体急性淋巴细胞白血病中的协同药物相互作用

HELIYON
IF3.6
2024-07-010
OAAI
The gray area of RQ-PCR-based measurable residual disease: subdividing the positive, below quantitative range category
LEUKEMIA
IF13.4
2024-05-173
OAAI
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines
LEUKEMIA
IF13.4
2024-05-145
OAAI
Idiopathic erythrocytosis: a germline disease?
2024-01-202
OAAI
Antibody Deficiency in Patients with Biallelic KARS1 Mutations (Sept, 10.1007/s10875-023-01584-7, 2023)

双等位基因KARS1突变患者的抗体缺乏 (2023,10.1007/s10875-023-01584-7,9月)

2023-11-030
OA
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia

高通量筛选作为小儿B细胞前体急性淋巴细胞白血病不良结局亚组的药物再利用策略

2023-11-018
OAAI
Antibody Deficiency in Patients with Biallelic KARS1 Mutations
2023-09-282
PRE
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease

miR-126确定了与最小残留疾病相关的静止和化疗耐药的人类b-all细胞亚群

LEUKEMIA
IF13.4
2023-08-282
PRE
The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)

世界卫生组织第5版血淋巴肿瘤分类: 淋巴肿瘤 (第36卷,1720页,2022)

LEUKEMIA
IF13.4
2023-07-1915
OAAI
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial
2023-07-0113
PRE